Brochure | June 11, 2020

Providing Uncommon Expertise For Your Oncology Program

Our award-winning, specialized early phase oncology team helps emerging and established biopharma, biotech, and pharmaceutical companies accelerate the advancement of early phase compounds through clinical testing.

The competitive landscape for oncology research is at an all-time high, and trial designs are increasing in complexity. Recent reports indicate that the success rate of investigational compounds approved for clinical use in cancer is the lowest among all diseases, and the likelihood of approval for investigational oncology drugs tested in Phase I trials is only 6.7 percent.1 Who you select as your CRO partner can have a significant impact on the success and/or failure of your clinical study and program. Who can you trust to help you with your development journey?

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: